» Articles » PMID: 21839745

Conformational Transformation and Selection of Synthetic Prion Strains

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2011 Aug 16
PMID 21839745
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Prion protein is capable of folding into multiple self-replicating prion strains that produce phenotypically distinct neurological disorders. Although prion strains often breed true upon passage, they can also transform or "mutate" despite being devoid of nucleic acids. To dissect the mechanism of prion strain transformation, we studied the physicochemical evolution of a mouse synthetic prion (MoSP) strain, MoSP1, after repeated passage in mice and cultured cells. We show that MoSP1 gradually adopted shorter incubation times and lower conformational stabilities. These changes were accompanied by structural transformation, as indicated by a shift in the molecular mass of the protease-resistant core of MoSP1 from approximately 19 kDa [MoSP1(2)] to 21 kDa [MoSP1(1)]. We show that MoSP1(1) and MoSP1(2) can breed with fidelity when cloned in cells; however, when present as a mixture, MoSP1(1) preferentially proliferated, leading to the disappearance of MoSP1(2). In culture, the rate of this transformation process can be influenced by the composition of the culture media and the presence of polyamidoamines. Our findings demonstrate that prions can exist as a conformationally diverse population of strains, each capable of replicating with high fidelity. Rare conformational conversion, followed by competitive selection among the resulting pool of conformers, provides a mechanism for the adaptation of the prion population to its host environment.

Citing Articles

Brain-derived tau oligomer polymorphs: distinct aggregations, stability profiles, and biological activities.

Cascio F, Park S, Sengupta U, Puangmalai N, Bhatt N, Shchankin N Commun Biol. 2025; 8(1):53.

PMID: 39809992 PMC: 11733013. DOI: 10.1038/s42003-025-07499-w.


α-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model.

So R, Amano G, Stuart E, Ebrahim Amini A, Aguzzi A, Collingridge G PLoS Pathog. 2024; 20(9):e1012517.

PMID: 39264912 PMC: 11392418. DOI: 10.1371/journal.ppat.1012517.


Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation.

Arar S, Haque M, Bhatt N, Zhao Y, Kayed R ACS Chem Neurosci. 2024; 15(7):1366-1377.

PMID: 38503425 PMC: 10995947. DOI: 10.1021/acschemneuro.3c00614.


Efficient interspecies transmission of synthetic prions.

Block A, Shikiya R, Eckland T, Kincaid A, Walters R, Ma J PLoS Pathog. 2021; 17(7):e1009765.

PMID: 34260664 PMC: 8312972. DOI: 10.1371/journal.ppat.1009765.


Modulating disease-relevant tau oligomeric strains by small molecules.

Cascio F, Garcia S, Montalbano M, Puangmalai N, McAllen S, Pace A J Biol Chem. 2020; 295(44):14807-14825.

PMID: 32737202 PMC: 7606668. DOI: 10.1074/jbc.RA120.014630.


References
1.
Supattapone S, Muramoto T, Legname G, Mehlhorn I, Cohen F, DeArmond S . Identification of two prion protein regions that modify scrapie incubation time. J Virol. 2001; 75(3):1408-13. PMC: 114047. DOI: 10.1128/JVI.75.3.1408-1413.2001. View

2.
Peretz D, Scott M, Groth D, Williamson R, Burton D, Cohen F . Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci. 2001; 10(4):854-63. PMC: 2373967. DOI: 10.1110/ps.39201. View

3.
Pattison I, Jones K . The possible nature of the transmissible agent of scrapie. Vet Rec. 1967; 80(1):2-9. DOI: 10.1136/vr.80.1.2. View

4.
Scott M, Foster D, Mirenda C, Serban D, Coufal F, Walchli M . Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell. 1989; 59(5):847-57. DOI: 10.1016/0092-8674(89)90608-9. View

5.
Peretz D, Williamson R, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G . Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 2001; 412(6848):739-43. DOI: 10.1038/35089090. View